The Sempulse HaloCRM™ Device

The HaloCRM™ device and the HaloCRM™ algorithm is Sempulse’s officially licensed implementation of the US Army’s Institute of Surgical Research ‘s (USAISR) Compensatory Reserve Measurement (CRM) algorithm, with enhancements, that runs on the Sempulse Halo device.

Sempulse’s Next generation Compensatory Reserve Diagnostics™ (CRD™) suite and its underlying Sempulse Compensatory Reserve Score™ (CRS™) biometric are currently under development and Validation, but both show promise in improving upon CRM.

HaloCRM™, CRD™, CRM, CRS™ are all trademarks and are under active development and not cleared for use by the FDA at this time.

Sempulse HaloCRM™

Sempulse Halo

The Sempulse Halo is an innovative, non-invasive vital signs monitor that offers real-time monitoring.

What is the HaloCRM™ algorithm?

The HaloCRM™ algorithm is an advanced hemodynamic status measurement that runs on the Sempulse HaloCRM™ device.

For more information on the HaloCRM™ algorithm and the technology behind it, check out these authoritative sources:

  1. US Army Tactical Combat Casualty Care (TCCC) Handbook, Version 5
  2. Superiority of compensatory reserve measurement compared with the Shock index for early and accurate detection of reduced central blood volume status from the NIH Website